These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 4943064)

  • 1. Tumor-induced skin heterogenization. II. Virus causing the phenomenon.
    Svet-Moldavsky GJ; Liozner AL; Mkheidze DM; Sokolov PP; Bykovsky AP
    J Natl Cancer Inst; 1970 Sep; 45(3):475-84. PubMed ID: 4943064
    [No Abstract]   [Full Text] [Related]  

  • 2. Tumor-induced skin heterogenization. 3. Immunologic and immunogenetic mechanisms.
    Liozner AL; Svet-Moldavsky GJ; Mkheidze DM
    J Natl Cancer Inst; 1970 Sep; 45(3):485-94. PubMed ID: 4943065
    [No Abstract]   [Full Text] [Related]  

  • 3. Heterogenization of normal tissues in oncogenesis. A skeptical review.
    Mariani T; Good RA
    Isr J Med Sci; 1973 Mar; 9(3):380-94. PubMed ID: 4575655
    [No Abstract]   [Full Text] [Related]  

  • 4. Tumor-induced skin heterogenization. I. Reciprocal relationship between tumors and skin grafts.
    Mkheidze DM; Liozner AL; Svet-Moldavsky GJ
    J Natl Cancer Inst; 1970 Sep; 45(3):465-73. PubMed ID: 4331640
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies of tumor antigens and tumor-specific immune mechanisms in experimental systems.
    Law LW
    Transplant Proc; 1970 Mar; 2(1):117-32. PubMed ID: 4330038
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic specificity of accelerated skin graft rejection with antigenic overlap in the H-2 system. Role of immune lymphocytes and antibodies].
    Brondz BD
    Biull Eksp Biol Med; 1972 Dec; 73(12):61-5. PubMed ID: 4118605
    [No Abstract]   [Full Text] [Related]  

  • 7. Alteration of skin in gross leukemia. V. Refutation of virus involvement.
    Mariani T; Maruyama Y
    J Natl Cancer Inst; 1974 Dec; 53(6):1661-4. PubMed ID: 4612164
    [No Abstract]   [Full Text] [Related]  

  • 8. [Rejection of non viral tumors caused by infection with murine sarcoma virus].
    Basombrio MA
    Medicina (B Aires); 1977; 37(2):127-32. PubMed ID: 197370
    [No Abstract]   [Full Text] [Related]  

  • 9. [Transplantable ascitic tumor derived from a mouse with moloney sarcoma: tumorigenic, antigenic and virologic properties (author's transl)].
    Weiland E; Weiland F
    Z Immunitatsforsch Exp Klin Immunol; 1974 Nov; 148(2):151-61. PubMed ID: 4283271
    [No Abstract]   [Full Text] [Related]  

  • 10. Syngeneic skin graft rejection associated with oncogenic viruses.
    Meeker WR; Yohn DS
    Am Surg; 1972 Oct; 38(10):563-8. PubMed ID: 4346738
    [No Abstract]   [Full Text] [Related]  

  • 11. [A tumor-associated virus causing heterogenation of the skin].
    Svet-Moldavskiĭ GIa; Mkheidze DM; Liozner AL; Bykovskiĭ AF
    Vopr Onkol; 1968; 14(4):60-4. PubMed ID: 4874849
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phenomenon of skin heterogenization by a tumor].
    Svet-Moldavskiĭ GIa; Mkheidze DM; Liozner AL
    Dokl Akad Nauk SSSR; 1967 May; 174(1):243-5. PubMed ID: 4914733
    [No Abstract]   [Full Text] [Related]  

  • 13. Are the neoantigens induced by chemical carcinogens or by leukaemogenic viruses particular to cancer cells?
    Mathé G
    Transplant Proc; 1969 Mar; 1(1):113-8. PubMed ID: 4944207
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunosuppression and oncogenic virus infections.
    Hirsch MS; Black PH; Proffitt MR
    Fed Proc; 1971; 30(6):1852-7. PubMed ID: 4330993
    [No Abstract]   [Full Text] [Related]  

  • 15. Summary: heterogenization.
    Mariani T
    Natl Cancer Inst Monogr; 1972 Dec; 35():321-4. PubMed ID: 4572831
    [No Abstract]   [Full Text] [Related]  

  • 16. [Oncornavirus, biological and immunological considerations].
    Chieco-Bianchi G
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(9):265-77. PubMed ID: 4125502
    [No Abstract]   [Full Text] [Related]  

  • 17. Tumor rejection and immunotherapy studies with simian virus 40-induced tumors.
    Blakeslee JR; von Muenchhausen W; Cox HR
    J Med; 1973; 4(4):233-47. PubMed ID: 4358481
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity of homograft rejection in vivo, assessed by inoculation of artificially mixed compatible and imcompatible tumor cells.
    Klein E; Klein G
    Cell Immunol; 1972 Sep; 5(1):201-8. PubMed ID: 5078988
    [No Abstract]   [Full Text] [Related]  

  • 19. Specific transplantation resistance against mouse tumour induced by mouse sarcoma virus (Harvey).
    Koldovský P; Turano A; Fadda G
    Folia Biol (Krakow); 1969; 17(3):224-5. PubMed ID: 5801814
    [No Abstract]   [Full Text] [Related]  

  • 20. Relationship between foreign H-2-like antigens on MCG4 sarcoma and the in vivo rejection of this tumor by syngeneic and semisyngeneic mice.
    García-Olivares E; Torres MD; Gutiérrez F; Osorio C
    Rev Esp Fisiol; 1982 Mar; 38(1):9-12. PubMed ID: 7100610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.